Your browser is no longer supported. Please, upgrade your browser.
Settings
AEZS Aeterna Zentaris Inc. daily Stock Chart
AEZS [NASD]
Aeterna Zentaris Inc.
Index- P/E- EPS (ttm)-0.75 Insider Own0.60% Shs Outstand20.18M Perf Week-9.40%
Market Cap18.21M Forward P/E- EPS next Y-0.64 Insider Trans0.00% Shs Float19.95M Perf Month-51.74%
Income-12.30M PEG- EPS next Q-0.17 Inst Own21.40% Short Float2.04% Perf Quarter-66.33%
Sales2.30M P/S7.92 EPS this Y121.90% Inst Trans5.37% Short Ratio2.98 Perf Half Y-80.51%
Book/sh-0.18 P/B- EPS next Y-136.20% ROA-51.10% Target Price5.50 Perf Year-46.60%
Cash/sh0.48 P/C1.88 EPS next 5Y- ROE- 52W Range0.81 - 5.57 Perf YTD-69.31%
Dividend- P/FCF- EPS past 5Y14.90% ROI157.40% 52W High-83.80% Beta1.13
Dividend %- Quick Ratio1.60 Sales past 5Y34.20% Gross Margin12.20% 52W Low11.06% ATR0.12
Employees22 Current Ratio1.70 Sales Q/Q0.00% Oper. Margin- RSI (14)19.57 Volatility10.56% 10.85%
OptionableYes Debt/Eq- EPS Q/Q107.50% Profit Margin- Rel Volume0.97 Prev Close0.92
ShortableYes LT Debt/Eq- EarningsNov 12 AMC Payout- Avg Volume136.41K Price0.90
Recom- SMA20-26.32% SMA50-49.01% SMA200-70.74% Volume130,957 Change-1.41%
Jul-19-17Reiterated Maxim Group Buy $2 → $4
May-10-17Reiterated H.C. Wainwright Buy $7.50 → $3
May-01-17Reiterated Maxim Group Buy $11 → $2
Jan-17-17Reiterated Maxim Group Buy $7 → $10
Dec-02-15Reiterated H.C. Wainwright Buy $11 → $12
Nov-24-15Reiterated H.C. Wainwright Buy $0.11 → $11
Nov-23-15Reiterated Maxim Group Buy $200 → $11
Apr-14-15Upgrade H.C. Wainwright Neutral → Buy $1.25
Nov-06-14Downgrade H.C. Wainwright Buy → Neutral
Jul-17-14Initiated H.C. Wainwright Buy $3
Jan-03-13Upgrade MLV & Co Hold → Buy $5.50
Oct-09-12Initiated Maxim Group Buy $9
Apr-02-12Downgrade MLV & Co Buy → Hold
Jun-07-11Initiated Oppenheimer Outperform $5.50
Apr-27-11Reiterated Canaccord Genuity Speculative Buy $2.75 → $4
Nov-29-10Initiated MLV Capital Buy $5.50
Feb-05-09Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-03-08Reiterated Canaccord Adams Buy $3.20 → $2.65
Apr-14-08Reiterated Canaccord Adams Buy $4.50 → $3.20
Oct-03-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
Oct-08-19 09:00AM  What Makes Aeterna Zentaris (AEZS) a New Buy Stock Zacks
Oct-04-19 04:59PM  Aeterna Zentaris Announces Appointment of New President and Chief Executive Officer GlobeNewswire
Sep-26-19 06:34AM  Can We See Significant Institutional Ownership On The Aeterna Zentaris Inc. (TSE:AEZS) Share Register? Simply Wall St. -5.13%
Sep-24-19 04:01PM  Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering GlobeNewswire
Sep-20-19 11:00AM  Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering GlobeNewswire -22.42%
Aug-20-19 11:16PM  Aeterna Zentaris Announces Director Change GlobeNewswire
Aug-13-19 05:45PM  Aeterna Zentaris (AEZS) Beats Q2 Earnings Estimates Zacks +11.16%
04:15PM  Aeterna Zentaris Reports Second Quarter 2019 Financial and Operating Results GlobeNewswire
Aug-01-19 10:33AM  Will Aeterna Zentaris (AEZS) Report Negative Q2 Earnings? What You Should Know Zacks -5.20%
Jul-01-19 10:30AM  Options Traders Expect Huge Moves in Aeterna Zentaris (AEZS) Stock Zacks
Jun-06-19 02:06PM  Aeterna Zentaris Provides Corporate Update GlobeNewswire -13.38%
May-08-19 06:04PM  Aeterna Zentaris Announces Results of Annual and Special Shareholders Meeting GlobeNewswire -11.32%
May-07-19 07:25PM  Aeterna Zentaris (AEZS) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:22PM  Aeterna Zentaris: 1Q Earnings Snapshot Associated Press
05:12PM  Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results GlobeNewswire
May-02-19 10:02AM  What's in the Cards for AEterna (AEZS) This Earnings Season? Zacks
Apr-29-19 10:31AM  Analysts Estimate Aeterna Zentaris (AEZS) to Report a Decline in Earnings: What to Look Out for Zacks
Mar-26-19 07:50PM  Aeterna Zentaris: 4Q Earnings Snapshot Associated Press
05:22PM  Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results GlobeNewswire
Mar-19-19 08:00AM  Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019 GlobeNewswire +5.50%
Mar-18-19 11:18AM  Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade Zacks
Mar-13-19 07:27AM  The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie Benzinga +8.40%
Mar-12-19 04:32PM  Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor GlobeNewswire
Mar-04-19 08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks -5.50%
Feb-27-19 09:57AM  The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris Zacks
Feb-26-19 08:55AM  4 Drug Stocks to Buy Despite Price Hearing Woes Zacks
Feb-14-19 10:45AM  The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna Zacks
Feb-13-19 08:36AM  5 Tiny Biotech Stocks With Superb Growth Potential Zacks
Jan-29-19 09:30AM  Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year? Zacks
08:48AM  Implied Volatility Surging for Aeterna Zentaris (AEZS) Stock Options Zacks
Jan-16-19 09:03AM  Aeterna Zentaris Receives European Marketing Clearance for Macimorelin GlobeNewswire -10.00%
Jan-09-19 09:50AM  Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan Zacks
Jan-07-19 09:30AM  Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year? Zacks
Dec-24-18 05:50PM  Aeterna Zentaris (AEZS) Stock Moves -1.16%: What You Should Know Zacks
Dec-21-18 05:04PM  Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore GlobeNewswire -5.82%
Dec-20-18 09:30AM  Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-17-18 05:50PM  Aeterna Zentaris (AEZS) Gains As Market Dips: What You Should Know Zacks
Dec-07-18 05:45PM  Aeterna Zentaris (AEZS) Stock Moves -0.54%: What You Should Know Zacks
Dec-04-18 12:51PM  Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? Zacks -5.43%
Nov-30-18 05:41AM  Can The Uptrend Continue for Aeterna Zentaris (AEZS)? Zacks +7.64%
Nov-19-18 09:00AM  4 Healthcare Stocks Taking a New Approach to Growth Trends ACCESSWIRE
08:00AM  Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency GlobeNewswire
Nov-16-18 10:50AM  4 Healthcare Stocks Turning Toward Tech For New Growth ACCESSWIRE +14.17%
07:40AM  Consolidated Research: 2018 Summary Expectations for Western Gas Partners, LP, HCA Healthcare, DHI Group, AEterna Zentaris, Tsakos Energy Navigation, and Acme United Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-06-18 07:54PM  Aeterna Zentaris: 3Q Earnings Snapshot Associated Press
06:14PM  Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results GlobeNewswire
08:00AM  Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC GlobeNewswire
Nov-01-18 08:20AM  Aeterna Zentaris Soars on Macrilen(TM) Out Licensing Deal, Analysts Review and Target ACCESSWIRE
08:00AM  Aeterna Zentaris Announces Novo Nordisk to acquire rights to Macrilen in United States and Canada GlobeNewswire
07:50AM  Todays Research Reports on Stocks to Watch: Aeterna Zentaris and AbbVie ACCESSWIRE
Oct-31-18 04:05PM  Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018 GlobeNewswire +67.69%
12:00PM  3 Healthcare Stocks Leading New Industry Trends ACCESSWIRE
Sep-25-18 08:00AM  Aeterna Zentaris Appoints Leslie Auld as Chief Financial Officer GlobeNewswire
Aug-10-18 07:27AM  What is Behind Aeterna Zentaris Incs (TSE:AEZS) Superior ROE? Simply Wall St.
06:30AM  Aeterna Zentaris Inc. to Host Earnings Call ACCESSWIRE
Aug-09-18 06:57PM  Aeterna Zentaris: 2Q Earnings Snapshot Associated Press
04:19PM  Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
Aug-02-18 04:05PM  Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018 GlobeNewswire
May-31-18 04:15PM  Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH GlobeNewswire -9.54%
May-29-18 08:44AM  Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% in Session Zacks +12.96%
May-25-18 08:44AM  VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher Zacks +6.41%
May-24-18 08:46AM  MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session Zacks
May-16-18 08:45AM  Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher Zacks
May-14-18 02:10PM  5 Top Profitable Stocks With Terrific Growth InvestorPlace
09:47AM  Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors Zacks
May-11-18 09:24AM  5 Top Profitable Stocks With Terrific Growth in the Offing Zacks +6.87%
May-08-18 04:15PM  Aeterna Zentaris Announces Results of Annual and Special Shareholders Meeting GlobeNewswire -5.79%
07:55AM  Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure Benzinga
May-07-18 06:41PM  Aeterna Zentaris: 1Q Earnings Snapshot Associated Press
04:15PM  Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results GlobeNewswire
May-01-18 05:05PM  Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018 GlobeNewswire
Apr-19-18 07:20AM  Wired News Anavex Life Sciences To Commence Phase-2 Study of ANAVEX(R)2-73 in Parkinsons Disease Dementia ACCESSWIRE
Apr-09-18 08:00AM  Aeterna Zentaris Files Management Information Circular GlobeNewswire
Mar-28-18 07:37AM  Aeterna Zentaris reports 4Q loss Associated Press -7.12%
07:00AM  Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results GlobeNewswire
06:30AM  Aeterna Zentaris Inc. to Host Earnings Call ACCESSWIRE
Mar-24-18 12:02PM  March Best Growth Stocks Simply Wall St.
Mar-21-18 04:05PM  Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018 GlobeNewswire
Mar-05-18 04:05PM  Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer GlobeNewswire -8.94%
07:45AM  Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit GlobeNewswire
Feb-18-18 11:02AM  Top TSX Growth Stocks To Buy Simply Wall St.
Jan-29-18 01:40PM  5 Great Breakout Stocks Offering Superlative Returns InvestorPlace
Jan-19-18 08:20AM  Zacks.com highlights: Sanchez Midstream Partners, Tecnoglass, Aeterna Zentaris, Ardelyx and Matrix Service Zacks
Jan-18-18 09:32AM  5 Great Breakout Stocks Offering Superlative Returns Zacks -5.39%
08:15AM  Heres Whats Moving Novartis And Aeterna Zentaris Right Now Market Exclusive
Jan-17-18 10:03AM  AEterna Zentaris Inc. (USA) (AEZS) Stock Fires Up to the Roof; Heres Why SmarterAnalyst +16.43%
07:00AM  Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN (macimorelin) from Aeterna Zentaris GlobeNewswire
07:00AM  Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen (macimorelin) in the U.S. and Canada GlobeNewswire
Dec-22-17 04:15PM  Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore GlobeNewswire -9.26%
Dec-21-17 10:55AM  Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold Yahoo Finance +34.33%
10:41AM  Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold Yahoo Finance Video
09:12AM  U.S. stocks remain on track to open near records after GDP data MarketWatch
08:55AM  Stocks push slightly higher, President Trump prepares to sign tax bill into law Yahoo Finance
08:23AM  Aeterna Zentaris' stock soars toward 8-month high after Macrilen granted marketing approval MarketWatch
08:22AM  IIROC Trade Resumption - Aeterna Zentaris Inc. Newsfile
07:20AM  Yahoo Finance Live: Market Movers - Dec 21st, 2017 Yahoo Finance Video
07:12AM  Heres How AbbVie (NYSE:ABBV) and Aeterna Zentaris Inc. (NASDAQ:AEZS) Just Picked Up Early Christmas Present Market Exclusive
Dec-20-17 07:00PM  AEterna Zentaris Inc. (USA) (AEZS) Investors Celebrate FDA Approval; Shares Skyrocket SmarterAnalyst
05:39PM  Canada's Aeterna gets FDA approval for growth hormone deficiency test Reuters
05:00PM  Aeterna Zentaris Announces FDA Approval of Macrilen (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency GlobeNewswire
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.